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Abstract
This study assessed the effect of changes in glycemic index (GI) and load (GL) onweight loss and glycated hemoglobin (HbA1c)
among individuals with type 2 diabetes beginning a vegan diet or diet following the 2003 American Diabetes Association (ADA)
recommendations. The study was a 22-wk, randomized trial of 99 participants with type 2 diabetes who were counseled to
follow 1 of 2 diet treatments. GI and GL changes were assessed based on 3-d dietary records. The relationships between GI/
GL and changes in weight and HbA1Cwere calculated. In an intention-to-treat analysis (n = 99), the vegan group reduced GI to
a greater extent than the ADA group (P, 0.05), but GL was reduced further in the ADA than the vegan group (P, 0.001). GI
predicted changes in weight (P = 0.001), adjusting for changes in fiber, carbohydrate, fat, alcohol, energy intake, steps per day,
group, and demographics, such that for every point decrease in GI, participants lost ~0.2 kg (0.44 lb). GI was not a predictor for
changes in HbA1C after controlling for weight loss (P = 0.33).Weight losswas a predictor of changes in HbA1C (P = 0.047). GL
was not related toweight loss or changes in HbA1C. A low-GI diet appears to be one of the determinants of success of a vegan
or ADA diet in reducing body weight among people with type 2 diabetes. The reduction of body weight, in turn, was predictive
of decreasing HbA1C. J. Nutr. 141: 1469–1474, 2011.
Introduction
Overweight and obesity are increasingly problematic in the US
and other countries. Two-thirds of U.S. adults are overweight or
obese (1) and the prevalence of type 2 diabetes among this
population is 9.3% (2). The use of a low-fat, low-glycemic index
(GI)12 vegan diet may be a useful strategy in promoting weight
loss and reducing risk of associated comorbidities. People
following vegan diets have a lower BMI than nonvegetarians,
as well as a lower prevalence of type 2 diabetes (3). Clinical trials
using vegetarian and vegan diets have demonstrated significant
improvements in body weight (4), glycemic control (5), and
cardiovascular risk factors (6) compared with conventional
therapeutic approaches.
Consumption of a diet with a high GI, a measure of blood
glucose response after consumption of a carbohydrate-containing
food (7), may be linked to an increased risk of type 2 diabetes,
heart disease, obesity, and metabolic syndrome (8,9). Diets with
a high GI and a high glycemic load (GL), which is the product of
a food’s GI and the amount of carbohydrate in that food, have
been associated with increased insulin resistance (10) and more
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frequent episodes of hypoglycemia among people with type 2
diabetes who are treated with insulin (11). Several prospective
and cross-sectional studies have examined the relationship
between GI or GL and the risk of developing type 2 diabetes
(10), but there have also been a number of randomized clinical
trials of GI and diabetes management (9,12). In a study by
Jenkins et al. (13), participants with type 2 diabeteswere randomly
assigned to a low-GI diet or a high-fiber diet. Participants in the
low-GI group had greater reductions in glycated hemoglobin
(HbA1c) and a greater increase in HDL cholesterol. The effect on
body weight did not reach significance in the intent-to-treat
analysis (P = 0.053) but was a major predictor of change in
HbA1c. Studies suggest that a low-GI diet may be more effective
at producing weight loss (9,11,12,14,15) and assisting with
weight maintenance (16) than a high-GI diet. In view of the
continuing debate over the utility of the GI and GL concepts in
diet selection (17), the effect of changes in GI and GL on weight
loss and changes in HbA1c were assessed among individuals
with type 2 diabetes in the context of both a vegan and a
conventional dietary approach to diabetes management.
Methods
The study design and exclusion criteria have been described elsewhere
(5). Briefly, participants with type 2 diabetes (fasting plasma glucose
concentration.6.94 mmol/L on 2 occasions or a prior diagnosis of type
2 diabetes with the use of hypoglycemic medications for $6 mo) were
recruited in 2 cohorts between 2003 and 2004. The protocol was
approved by the George Washington University Institutional Review
Board. All participants gave written informed consent.
Dietary intervention. Participants were randomly assigned to follow
either a low-fat, low-GI vegan diet (vegan) or individualized diets based
on the 2003 American Diabetes Association (ADA) dietary recommen-
dations (17). The vegan diet (;10% of energy from fat, 15% protein,
75% carbohydrate) consisted of vegetables, fruits, grains, and legumes,
and participants were not given an energy intake restriction (5). The
ADA diet (15–20% protein, ,7% saturated fat, 60–70% carbohydrate
and monounsaturated fats; cholesterol #200 mg/d) was individualized
based on body weight and plasma lipid concentrations (17). ADA
participants with a BMI .25 kg/m2 were prescribed energy intake
deficits of 500–1000 kcal.13 Both groups were instructed to limit
alcoholic drinks to no more than 2 drinks/d for men and 1 drink/d for
women. Participants met with their assigned group each week for 22 wk
where they learned about food preparation and meal planning (5).
Outcome measures. Over the course of the 22-wk study, 3-d weighted
food records, body weight, physical activity, and HbA1c were collected
at 0, 11, and 22 wk and methods for collection have been described
elsewhere (5). Physical activity was assessed over a 3-d period by using a
pedometer (OmronHJ-112) and with the Bouchard 3-d Physical Activity
Record (18). Dietary measure, including GI and GL (both using the
bread reference), were collected using 3-d dietary records that were
analyzed using Nutrition Data System for Research (NDS-R) software
version 5.0, (Nutrition Coordinating Center, University of Minnesota,
Food and Nutrient Database 35, released May 2004). All foods and
beverages, including alcohol, were included in the GI and GL calcula-
tions. Results were totaled for each day and averaged for the 3 d of
dietary recording. The GI and GL values of the diet were obtained from
NDS-R calculations. For GI, the ingredient proportion of available
carbohydrate was multiplied by the ingredient GI to get the proportional
GI for each ingredient. For GL, ingredient available carbohydrate was
multiplied by the ingredient GI and divided by 100 to obtain the
ingredient GL. Selection of GI values for NDS-R’s database has been
discussed in more detail elsewhere (19).
Statistical analyses. Values presented are means6 SD unless otherwise
noted. Race was dichotomized into white compared with nonwhite. Two
sample t tests were conducted to determine whether outcomes were
significantly different between groups and paired sample t tests were
used to examine within-group differences. ANOVAwas used to examine
differences in changes in variables among the 3 tertiles of change in GI.
The Tukey’s test was used for post hoc analyses among the 3 groups.
Intention-to-treat analysis was conducted by bringing baseline values
forward in cases where participants did not complete 22-wk assessments.
A linear regression model was analyzed with weight loss as the
dependent variable and GI as an independent variable, adjusting for
age, race, sex, group assignment, and changes in energy intake, fiber,
carbohydrate, fat, and steps per day. An additional model using the same
independent variables and controls was analyzed for changes in HbA1c.
Weight loss was also included as a covariate in the model with HbA1c as
the dependent variable to control for the effect of weight loss on HbA1c.
Similar models with GL were run with HbA1c and weight loss as
dependent variables. For the GL models, however, changes in carbohy-
drate were not included as a covariate, because carbohydrate is included
in the calculation of GL. All models were run with and without inclusion
of the main effect of diabetes medication changes and an interaction term
for diabetes medication changes with changes in GI to assess the effect
modification of diabetes medication adjustments, because change in
diabetes medications can interact with changes in weight and HbA1c (5).
SPSS (SPSS for Windows, 17.0.0 2008, SPSS) was used for analyses with
a P-value of 0.05 used to indicate significant differences.
Results
Of 1049 individuals screened by telephone, 99 met the partic-
ipation criteria and were randomly assigned to either the vegan
(n = 49) or ADA (n = 50) group (5). The reasons for exclusion
can be found in Supplemental Figure 1. All participants com-
pleted laboratory assessments; however, 11 participants did not
complete diet records at 22 wk (n = 3 vegan, n = 8 ADA). The
mean percent of meetings participants attended in the vegan
(75.8 6 21.5%) or ADA groups (65.6 6 32.3%) did not differ
(P = 0.12). Baseline characteristics, measurements, or nutrient
intakes also did not differ between diet groups (5). There were
no differences in baseline demographic characteristics among
those in tertile 1 of GI change (GI $0), tertile 2 (20.001 to
26.46), and tertile 3 ($26.47) (Table 1). Changes in steps per
day and self-reported energy expenditure revealed no significant
differences among tertiles. Because weight was a calculation
within the 3-d activity records, pedometer data were used in the
analyses that required a control for changes in physical activity.
Pedometer data were incomplete for 3 participants in the ADA
group at baseline and were not included in the analyses.
There were significant differences among tertiles in changes
in energy, percent energy from carbohydrate, total fat (grams
and percent), fiber (total, soluble, and insoluble), and body
weight (Table 2). Those in the tertile with the greatest decrease
in dietary GI (tertile 3) had a greater increase in percent energy
from carbohydrate (P = 0.02) and total fiber (P = 0.01), soluble
fiber (P = 0.04), and insoluble fiber (P = 0.003) and a greater
decrease in total fat (percent and grams; P = 0.003) and body
weight (P = 0.004) than those in tertile 1 of change in GI.
Including all participants (n = 99) in an intention-to-treat
analysis, the vegan diet group reduced their GI (25.46 8.2) to a
greater extent than did the ADA group (21.7 6 8.6) (P = 0.03),
whereas the reduction in GL was greater in the ADA group
(237.4 6 52.9) than the vegan group (9.5 6 56.2) (P , 0.001).
Both groups decreased their energy intake, but there was no
difference between groups (P = 0.43) (20). At 22 wk, percent
energy from carbohydrates was higher in the vegan group13 1 kcal = 4.184 kJ.
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(70.8 6 10.6) than in the ADA group (47.8 6 9.7) (P , 0.001),
percent energy from total fat was lower in the vegan group
(17.9 6 7.0) than in the ADA group (32.8 6 7.4) (P , 0.001),
and percent energy from protein was lower in the vegan group
(14.7 6 4.9) than in the ADA group group (21.2 6 4.0) (P ,
0.001). Total fiber intake was also higher in the vegan group
(35.4 6 14.4 g/d) than in the ADA group (18.3 6 7.7) (P ,
0.001), as were soluble and insoluble fibers (P , 0.001) (20).
Changes in GI were correlated with changes in fat intake (r =
0.36; P , 0.001) but not with carbohydrate or protein (P .
0.05). Changes in carbohydrate were correlated with GL (r =
0.49; P , 0.001) but not fat or protein (P . 0.05).
Changes in GI predicted changes in weight (P = 0.001),
adjusting for changes in fiber, carbohydrate, total fat, alcohol,
energy intake, steps per day, and demographic characteristics
and group assignment, such that for every point decrease in GI,
participants lost ~0.2 kg (0.44 lb) (Table 3). Ethnicity was also a
predictor of mean weight change (6SE) with whites (26.36 0.6
kg) losing more weight than nonwhites (23.8 6 0.6 kg) (P =
0.01). A model including main effects and an interaction term
between changes in GI and changes in diabetes medications
showed the interaction to be nonsignificant (P = 0.42) and was
thus not included in the main model. Change in GI was not a
predictor of HbA1c (P = 0.08) and remained nonsignificant after
adjustment for weight loss (P = 0.33) (Table 4). Weight loss
remained the only significant predictor (P = 0.047) of HbA1c
changes such that each kilogram of body weight lost corre-
sponded to a 0.06-point decrease in HbA1c. Weight loss
remained significant after further adjustment for the interaction
of change in GI with change in diabetes medications (P = 0.03).
Because changes in fat intake were not correlated with GL,
dietary fat was not included in the models for GL. GL was not a
predictor of weight loss (P = 0.29), adjusting for changes in fiber,
alcohol, energy intake, steps per day, and group assignment and
demographic characteristics. Only change in steps per day
predicted change in weight (P = 0.001). A model including main
effects and an interaction term between changes in GL and
changes in diabetes medications showed the interaction were
nonsignificant (P = 0.50) and thus were not included in the main
model. A similar model with changes in HbA1c as the dependent
variable approached significance (P = 0.053) but was significant
after the addition of weight loss as a covariate (P = 0.009; model
R2 = 0.24). Weight loss was the only predictor of changes in
HbA1c (B = 0.07; P = 0.01); GL was not (B = 0.001; P = 0.70).
Weight loss remained the only predictor (B = 0.06; P = 0.02) of
HbA1c changes after further adjustment for the interaction
between diabetes medication changes and changes in GL such
that every 1-kg decrease in weight resulted in a 0.06-point drop
in HbA1c.
Discussion
Our objective in this study was to assess the effect of changes inGI
and GL on weight loss and changes in HbA1c among individuals
with type 2 diabetes in the context of a vegan diet and the 2003
ADA dietary recommendations while controlling for dietary and
demographic variables. Vegan diets have been shown to be
effective in the treatment of overweight (4) and type 2 diabetes
(5). Low-GI and -GL diets have also demonstrated effectiveness in
producing weight loss (9,14,15), assisting with weight mainte-
nance (16), and improving glycemic control among individuals
with type 2 diabetes (9,12,13). Both diet groups reduced their
energy intake to equal levels. Of interest is that the ADA group
was given an energy reduction prescription, whereas the vegan
group was not required to restrict energy intake.
In this dietary intervention, individuals in the ADA diet group
had greater reductions in GL than the vegan group, but the
vegan diet group reduced the GI of their diets more than did the
ADA group. The vegan diet group also increased intakes of both
soluble and insoluble fiber more so than the ADA group (20).
The overall reductions in GI in the present study were modest.
One difficulty in assessing the effect of GI on health outcomes is
that GI can be associated with fiber and carbohydrate intake. In
the present study, independent of changes in carbohydrate and
fiber, decreases in GI were associated with decreases in weight.
Changes in GL were not associated with weight loss. These
findings suggest that overweight individuals with type 2 diabetes
may benefit not only from increased fiber but specifically from a
reduction in the GI of their diets. GI was not a significant
predictor of HbA1c after controlling for weight loss, which was
the only significant variable. It is possible that small reductions
in GI may be associated with weight loss, with HbA1c reductions
as a secondary effect. Greater reductions in GI may be required to
detect an independent effect on HbA1c (13). Changes in GL were
not associated with improvements in HbA1c.
The utility of the GI in a clinical setting has been controver-
sial (17). In a study examining type 2 diabetes incidence among
men and women, high-GI diets were associated with an in-
creased risk of diabetes (10), a finding confirmed even after
adjusting for potential confounders such as BMI and family
history (21). In a study of older adults, however, which relied on
a single follow-up FFQ, researchers did not find a higher
TABLE 1 Baseline demographic information of participants in a
dietary intervention for type 2 diabetes by tertile of
change in glycemic index (GI)
Tertiles of change in GI
P 1Tertile 1 Tertile 2 Tertile 3
n 40 27 32
Age,2 y 53.7 (35–75) 59.0 (40–82) 53.9 (26–82) 0.07
Sex3 0.87
Male 15 (37) 11 (41) 14 (44)
Female 25 (63) 16 (59) 18 (56)
Race, ethnicity3 0.364
Black, non-Hispanic 19 (47) 8 (30) 17 (53)
White, non-Hispanic 15 (38) 15 (55) 13 (41)
White, Hispanic 4 (10) 1 (4) 1 (3)
Asian, non-Hispanic 2 (5) 3 (11) 1 (3)
Marital status3 0.07
Not married 11 (27) 3 (11) 12 (37)
Married 29 (73) 24 (89) 20 (63)
Education3 0.31
High school, partial or graduate 5 (14) 3 (14) 1 (4)
College, partial or graduate 20 (56) 10 (45) 21 (72)
Graduate degree 11 (30) 9 (41) 7 (24)
Occupation3 0.55
Employed 8 (20) 8 (30) 6 (19)
Retired or unemployed 32 (80) 19 (70) 26 (81)
BMI,5 kg/m2 34.8 6 7.3 34.6 6 9.1 35.1 6 6.1 0.97
1 P-values for continuous variables refer to t test for 2 comparisons and ANOVA for 3
comparisons. x2 was used for categorical variables.
2 Data are mean (range).
3 Data are n (%).
4 P-value calculated for race distribution; for ethnicity (Hispanic vs. non-Hispanic) P =
0.40 for tertiles of change in GI.
5 Data are mean 6 SD.
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incidence of type 2 diabetes among people in the highest quintiles
of dietary GI (22).
In this 22-wk intervention, GI, but not GL, was predictive of
weight loss. As previously reported, body weight was reduced to
a greater extent in the low-GI vegan group among diabetes
medication-stable participants compared with those in the ADA
group (5). The participants in the vegan diet group decreased
their dietary GI more so than those in the ADA group. High-GI
diets may be less satiating and more palatable and possibly favor
body fat storage compared with low-GI diets, which may be why
a decrease in GI in the present study was associated with
decreases in weight (12). Studies examining low-GI diets for
weight loss have tended to show benefits in terms of body weight
or body fat reduction or both (11). Other studies have found no
differences in weight loss between participants consuming a low-
or high-GI diet (23), whereas others have found health benefits
other than weight loss, such as improvements in cardiovascular
risk factors (24). Studies utilizing low-GL diets for weight loss
have also observed improvements in cardiovascular outcomes
but not weight loss (25). For example, several randomized
controlled trials have found no difference in weight loss between
a low-GL diet and a low-fat diet, but have observed improve-
ments in HbA1c (after adjustment for diabetes medications)
(26), HDL cholesterol (27), C-reactive protein (28,29), blood
pressure (28), and TG (28).
Also, among medication-stable participants, the vegan group
decreased its mean HbA1c to a greater degree than did the ADA
group (5). Although GI was not a significant predictor of HbA1c
after controlling for weight loss, other aspects of the vegan diet
may have resulted in beneficial changes in HbA1c. The reduced
fat content of a vegan diet has been hypothesized to reduce
intramyocellular lipid, a contributor to insulin resistance (30).
Type of dietary fat also can affect insulin resistance. Diets high in
saturated fat have been associated with increased insulin
resistance (31), whereas polyunsaturated fats appear to be
protective (32). Increased fiber has been shown to improve
glycemic control (10). In the present study, there was a treatment
difference in fiber intake, with the vegan group consuming
16 g/d of fiber more than the ADA group. As with GI, so fiber
intake may also be significantly related to weight loss. However,
TABLE 2 Changes in daily energy and macronutrient intakes, glycemic index (GI), glycemic load (GL),
hemoglobin HbA1c, body weight, and physical activity among the 3 tertiles of change in GI
among vegan and American Diabetes Association (ADA) diet group participants
Change in outcomes from
baseline to 22 wk1
Tertiles of change in GI
P 3Tertile 1, n = 402 Tertile 2, n = 272 Tertile 3, n = 322
Energy,4 kcal 2213 6 485 2425 6 381 2458 6 449 0.046
Carbohydrate, g 2.7 6 81.6 212.2 6 78.2 7.9 6 75.3 0.60
Carbohydrate, % 7.1 6 15.2 10.7 6 15.4 17.4 6 15.9a 0.02
Protein, g 213.1 6 23.2 219.5 6 19.6 221.8 6 30.2 0.31
Protein, % 21.1 6 2.9 20.2 6 5.0 20.3 6 6.2 0.69
Total fat, g 217.2 6 29.5 230.5 6 32.1 241.9 6 31.1a 0.01
Total fat, % 24.9 6 12.5 28.7 6 12.8 215.0 6 12.0a 0.01
Saturated fat, g 8.3 6 8.2 10.6 6 6.6 8.0 6 6.1 0.33
Alcohol, g 20.7 6 3.7 21.9 6 7.2 20.1 6 5.1 0.42
Total fiber, g 3.5 6 12.4 8.2 6 11.5 13.2 6 13.9a 0.01
Soluble fiber, g 0.9 6 3.1 2.1 6 3.0 2.8 6 3.7a 0.046
Insoluble fiber, g 2.6 6 9.4 6.3 6 8.9 10.3 6 10.6a 0.01
GI 4.0 6 4.9 23.3 6 2.0 213.2 6 5.3a ,0.001
GL 4.5 6 60.8 224.1 6 55.8 229.1 6 55.2a 0.03
bA1c, % 20.5 6 1.3 20.8 6 0.8 21.0 6 1.2 0.22
Weight, kg 23.7 6 3.8 24.8 6 4.4 27.0 6 4.7a 0.01
Pedometer readings,2 steps/d 5547 6 2724 2339 6 3332 6962 6 4394 0.15
1 Data are means 6 SD. aDifferent from tertile 1, P , 0.05.
2 The 22 wk data included all individuals with data at baseline, n = 49 (vegan group) and 50 (ADA group), with the exception of pedometer
data [3 missing at baseline from ADA group, so n = 37 (tertile 1), 27 (tertile 2), and 32 (tertile 3)].
3 Listed P-values are for ANOVA of comparisons among the three tertiles of change in GI (baseline to 22 wk).
4 Dietary data were reported from 3-d food records. 1 kcal = 4.184 kJ.
TABLE 3 Relationship of glycemic index (GI) with
weight loss after a 22-wk dietary intervention
comparing a low-fat vegan diet to diets following the
recommendations of the American Diabetes
Association (ADA), as determined by linear






Model F (11, 95) = 3.43, R2 = 0.31 0.001
Gender 1.40 0.87 1.61 0.11
Ethnicity, white vs. non-white 22.45 0.89 22.75 0.01
Age, y 0.03 0.05 0.62 0.54
Diet group assignment, vegan vs. ADA diet 20.98 1.14 20.86 0.39
Changes in energy intake,1,2 kcal/d 0.001 0.01 0.25 0.80
Changes in GI1 0.19 0.05 3.48 0.001
Changes in carbohydrate,1 g/d 20.01 0.02 20.37 0.71
Changes in total fat,1 g/d 20.01 0.06 20.19 0.85
Changes in fiber,1 g/d 0.02 0.04 0.35 0.73
Changes in alcohol intake,1 g/d 0.04 0.09 0.44 0.66
Changes in physical activity,3 steps/d 0.0001 0.0001 22.35 0.02
1 All dietary variables in the model are changes in intake from baseline to 22 wk (22 wk
intake – baseline intake).
2 1 kcal = 4.184 kJ.
3 Physical activity (assessed using a pedometer) in the model is change in mean steps
per day from baseline to 22 wk (22 wk mean steps per day –baseline mean steps per
day).
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GI was a significant predictor of weight loss after adjustment for
changes in fiber intake. In addition, decreasing GI may promote
other beneficial health effects for those with diabetes. A previous
clinical trial also found that altering the GI of the diet had no
significant effect on HbA1c, possibly related to a low HbA1c at
study entry (33). But the study did observe beneficial effects on
postprandial glucose, C-reactive protein, and b-cell function
(33) and a further study with higher HbA1c entry levels reported
a benefit for both HbA1c and HDL cholesterol (13). In the
present study, GL did not seem to be associated with changes
with HbA1c, even after adjusting for changes in diabetes
medications. Other studies have found no differences in weight
loss between those consuming a low-GL diet compared with a
low-fat diet but have found beneficial effects of a low-GL diet on
HbA1c, after adjustment for diabetes medication (26).
The present study has several strengths, including controlling for
fiber intake, an intention-to-treat design, and applicability outside
the research setting. A study limitation is that the effect of GI or GL
on glycemic control was not the primary objective of this study.
Other limitations include the relianceon self-reporteddietary intake.
The results of this study suggest that low-GI vegan diets may
have specific advantages given the high prevalence of obesity in
type 2 diabetes (34), the beneficial effect of weight loss on all
aspects of metabolism, and the tendency of hypoglycemic
medications (with the exception of metformin and a glycosidase
inhibitors) to promote weight gain (35). These findings provide
additional support for the use of low-GI diets in the treatment of
obesity. Even the relatively small reductions in GI in the present
study corresponded with weight loss, which in turn appeared to
aid in lowering HbA1c levels. These findings provide support for
encouraging patients with diabetes to favor low-GI foods.
Nonpharmacologic means of improving diabetes control have
become increasingly attractive given questions regarding the
cardiovascular benefits and risks of currently used hypoglycemic
drugs to achieve tight glycemic control (36).
In conclusion, consumption of low-GI foods, but not a low-
GL diet, appears to be one of the determinants of success of vegan
or ADA diets in reducing HbA1c and body weight. Additional
studies to lower the dietary GI further than was accomplished in
the present study by specifically incorporating low-GI foods, such
as peas, beans, and lentils, would be of interest to examine the
extent to which they can demonstrate further improvements in
the metabolic advantages of therapeutic diets.
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